• Home
  • Do I Qualify?
  • About VALIANT
  • Clinical Research
  • Site Locations
  • English
  • Español
  • English
  • Español
  • Français
  • English
  • Português
  • Deutsch

VALIANT: A clinical research study for young people and adults with C3G or MPGN

VALIANT is a clinical research study evaluating the safety and effectiveness of an investigational medication in young people and adults with C3G (primary C3 glomerulopathy) or IC-MPGN (immune complex membranoproliferative glomerulonephritis).

Find Out if You May Qualify
Find Out if You May Qualify

VALIANT: A clinical research study for young people and adults with C3G or MPGN

VALIANT is a clinical research study evaluating the safety and effectiveness of an investigational medication in young people and adults with C3G (primary C3 glomerulopathy) or IC-MPGN (immune complex membranoproliferative glomerulonephritis).

  • Home
  • Do I Qualify?
  • About VALIANT
  • Clinical Research
  • Site Locations
  • Privacy Policy
  • Terms of Service
  • www.theVALIANTstudy.com
  • The VALIANT STUDY and the VALIANT STUDY logo are trademarks of Apellis Pharmaceuticals, Inc. Other trademarks referenced herein are the property of their respective owners.
    ©2021 Apellis Pharmaceuticals, Inc. All rights reserved.
    © Design and code copyrights apply 2021 X Factor Advertising, Inc. - 08/22 - MED-US-PEGC3G-21-00001 v6.0